An Ayurvedic Approach to Amyotrophic Lateral Sclerosis - A Case Report
Abstract
Amyotrophic Lateral Sclerosis (ALS) is the most common form of progressive motor neuron disease, which characterised by progressive degeneration of cells of the lower cranial motor nuclei, anterior horn cells of the spinal cord and neurons of the motor cortex extending to the pyramidal tracts. ALS with multifocal onset might exhibit muscle stiffness & weakness in upper and lower limbs, muscle twitching, atrophy, slurred speech, dysphagia and loss of dexterity. In Ayurveda contexts, the signs and symptoms pertaining to ALS can be related to Kaphavruta Udanavata. In the present study the patient was presented with slurred speech, dyspnoea, reduced strength in right pollex, digitus secundus & medius, difficulty grasping objects in right hand, heaviness in right upper limb and dysphagia. The treatment administered were Snehana, Swedana, Matra Basti, Shiropichu and Shamana Oushadhi for a period of 42 Days (In patient – 12 days & Out patient – 30 days). The functional rating scale for ALS- revised (ALSFRS-R) was used for assessment. The ALSFRS-R scale before the treatment was 23 which was increased to 29 With remarkable improvement in dysphagia and moderate improvement in speech, strength in right pollex, digitus secundus and Medius and dyspnoea. The treatment was probably effective in preventing the late-stage complications of the disease, thereby improving the quality of life.
Downloads
References
Goldman L, Schafer AI, editors. Goldman-Cecil Medicine. 26th ed. Vol. 1. Elsevier; 2016. 2485 p.
Munjal YP, editor. API Textbook of Medicine. 9th ed. Mumbai: The Association of Physicians of India; 2012. 1477 p.
Munjal YP, editor. API Textbook of Medicine. 9th ed. Mumbai: The Association of Physicians of India; 2012. 1477 p.
Petrov D, Mansfield C, Moussy A, Hermine O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci. 2017;9:68.
Agnivesha, Yadavji T, editor. Commentary Ayurveda Deepika of Chakrapanidatta on Charaka Samhitaof Agnivesha, Chikitsasthana, Vatavyadhi Chikitsa Adhyaya. 1st ed. Varanasi: Chaukhamba Surbharati Prakashan; 2016. p. 626.
Agnivesha, Yadavji T, editor. Commentary Ayurveda Deepika of Chakrapanidatta on Charaka Samhita of Agnivesha, Chikitsasthana, Vatavyadhi Chikitsa Adhyaya. 1st ed. Varanasi: Chaukhamba Surbharati Prakashan; 2016. p. 624.
Vagbhatta A, Tripathi RD, editors. Ashtanga Samgraha. 3rd ed. Varanasi: Chaukhamba Sanskrit Pratishthana; 2003. Sutrasthana, Chapter 3, Verse 63, p. 50.
Shiwaji DS, Sadashiv AJ. Pharmacodynamics of Bashpa Sweda. Int Ayurvedic Med J. 2014;2(4):4.
Sushruta. Sushruta Samhita. Sarma PV, editor. 1st ed. Varanasi: Caukhambha Bharati Academy; 1999.
Padmakiran C, Prasad UN, Kumar KN. Analytical study of nirgundi taila. J Biol Sci Opin. 2015;3(3):122-127.
Kumar P, Rao RP. Role of Jambeera Pinda Sweda as palliative therapy in Janu Sandhigatavata (OA Knee Joints) - A clinical study. Int Ayurvedic Med J [Internet]. 2018 [cited 2018 Oct].
Vagbhatta A. Sidha Basti Kalpa Adhyaya, Chapter 5, Verse 24. In: Sharma S, editor. Kalpasthana. Ashtanga Samgraha. 4th ed. Varanasi: Chaukhamba Sanskrit Series Office; 2016. p. 605.
Subhan F, Karim N, Gilani AH, Sewell RD. Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles. Phytother Res [Internet]. 2010 [cited 2019 Mar 26];24(5):686-91.
Kalshetti P, Alluri R, Thakurdesai P. Antidepressant and anti-anxiety effect of ellagic acid from Punica granatum L. rind in olfactory bulbectomy model in rats. Int J Pharm Sci Rev Res. 2015;34(1):197-204.
Nishteswar K, Vaidyanath R. Sahasrayogam; Sanskrit text with English Translation, Gutika Prakarana, Chapter 9, Verse 54. Reprint ed. Varanasi: Chaukambha Sanskrit Series Office; 2020. p. 346.
V P H. Rasayogasagara. Vol. 1, Verse 1813-5. Varanasi: Chaukambha Krishnadas Academy; 192. 2003.
Rasa Tantra Sara-Sidha Yoga Sangraha Kharaliya Rasayana.
Das G, Mishra B, Shastri AD. Apasmara Rogadhikara, Verses 40-43. In: Shastri RD, editor. Bhaishajya Ratnavali. Reprint 2005. 131-2 ed. Varanasi: Chaukhambha Sanskrit Prakashan; 2005.
Das G, Mishra B, Shastri AD. Raktapitta Rogadhikara, Verses 102-6. In: Shastri RD, editor. Bhaishajya Ratnavali. Reprint 2005. 131-2 ed. Varanasi: Chaukhambha Sanskrit Prakashan; 2005. p. 701.
Nishteswar K, Vaidyanath R. Sahasrayogam; Sanskrit text with English Translation, Parishishta Prakarana, Chapter 10, Verse 110. Reprint ed. Varanasi: Chaukambha Sanskrit Series Office; 2020. p. 403.
Sharangadhara. Sharangadhara Samhita of Sharangadhara. Madhyamakhanda; Kwathaadi Kalpana:6,88-94. Reprint 2016. Varanasi: Chaukhamba Publications; 2015. p. 97.
Suganthy N, Devi KP, Nabavi SF, Braidy N, Nabavi SM. Bioactive effects of quercetin in the central nervous system: focusing on the mechanisms of actions. Biomed Pharmacother. 2016;84:892-908.
Shastri RV. Atha Vajikaranaprakaranam Bhaisajyaratnavali. Vidyotini-Hindivyakhya-Vimarsh-Parishishtasahita. Varanasi: Chaukhamba Sanskrit Bhavan; 2002. p. 796-7.
Souza AC, Bruning CA, Acker CI, Neto JS, Nogueira CW. 2-Phenylethynyl-butyltellurium enhances learning and memory impaired by scopolamine in mice. Behav Pharmacol. 2013;24:249-54.
Schroeter H, Williams RJ, Matin R, Iversen L, Rice-Evans CA. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radic Biol Med. 2000;29:1222-33.
Sarma SS, Angadi RD. Rasa Tarangini. Varanasi: Chaukhamba Surbharati Prakashan; 2015. p. 264.
Sen SG, Mishra SN. Bhaishajya Ratnavali. 1st ed. New Delhi: Chaukhamba Sanskrit Pratishthan; 2013. Shloka No. 141.
Forestier J. Rheumatoid arthritis and its treatment with gold salts - results of six years of experience. J Lab Clin Med. 1935;20:827-40.
Sharma PV. Priya Nighantu. Varanasi: Chaukhamba Surbharathi Prakashan; 2004. p. 83.
Balakrishnan R, Cho DY, Kim IS, Seol SH, Choi DK. Molecular mechanisms and therapeutic potential of α- and β-asarone in the treatment of neurological disorders. Antioxidants (Basel). 2022;11(2):281.
Varuni BG. An open-labelled clinical study to evaluate the safety and efficacy of Anuloma DS in improving constipation. Indian J Clin Pract. 2023;34(2):86-92.

Copyright (c) 2025 Merlyn T Jones, Vasantha B, Muttappa Totad, Amarnath Bekal, Soorya PR, Rakshitha J

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.